Tag:
Accord
Latest Headlines
Latest Headlines
FDA: TriLipix may not cut patients' heart risks
The questions about Abbott Laboratories' cholesterol drug TriLipix aren't going away. The FDA issued a safety communication saying the drug may not lower a patient's risk of heart attack or stroke.
AZ settles another Seroquel patent suit, defends Crestor
Two big questions about AstraZeneca's ( $AZN ) intellectual property today: Has the domino effect from AstraZeneca's Seroquel XR patent settlement begun? And will AstraZeneca persuade an appeals court
